HOME >> BIOLOGY >> NEWS
Ecology center awarded $21-million by National Science Foundation

(Santa Barbara, Calif.) -- The National Science Foundation (NSF) has renewed and increased funding for The National Center for Ecological Analysis and Synthesis (NCEAS), which is based at UC Santa Barbara. Over the next five years, the unique national think tank for ecologists will receive a total of $18.4-million, an increase of $1.6-million over the previous award.

In addition, the NSF will provide $2.6-million to advance the center's research on the management of complex ecological information.

NCEAS is widely recognized as the premier international center for collaborative research in ecological synthesis. This is the second time that the NSF has renewed and increased funding for the pioneering center, which has been in operation for 11 years.

"NCEAS has made it possible for thousands of ecological researchers to study the big picture in a way that was impossible just a decade ago," said Michael Witherell, UCSB vice chancellor for research. "The NSF renewal recognizes the fact that NCEAS has transformed the study of ecology, and the field cannot succeed without it."

The National Science Foundation established the National Center for Ecological Analyses and Synthesis in 1995. Recognizing the potential value of utilizing existing data on ecology and the environment, and the need for new approaches to assembling, accessing, and synthesizing information, the ecological community rallied around the idea of creating a synthesis center.

"The center promotes extensive collaboration among scientists and students from many disciplines and their efforts have generated a greater understanding of natural systems and the means to conserve and manage them," said Jim Reichman, director of NCEAS and a professor of ecology, evolution, and marine biology at UCSB.

In research that spans the spectrum from genes to the biosphere, the innovative center provides a fertile arena for interdisciplinary collaboration, focusing on
'"/>

Contact: Eileen Conrad
eileen.conrad@ia.ucsb.edu
805-893-8726
University of California - Santa Barbara
28-Sep-2006


Page: 1 2

Related biology news :

1. Springer launches Theoretical Ecology
2. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
3. Ecology in an era of globalization
4. Geological Approaches to Coral Reef Ecology
5. NSF, NIH award Ecology of Infectious Diseases grants
6. Carnegies Global Ecology inks partnership with Japanese satellite firm
7. Special issue of the Journal of Industrial Ecology focuses on eco-efficiency
8. NSF, NIH award Ecology of Infectious Diseases grants
9. Ecology must be part of research on renewable energy
10. Highlights in the June 2005 issue of Frontiers in Ecology and the Environment
11. Highlights from the April issue of Ecology

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ecology center awarded million National Science Foundation

(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
(Date:4/9/2015)... Synaptics Inc. (NASDAQ: SYNA ), a leading ... will report financial results for the third quarter of ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-438-5524 (conference ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
(Date:4/17/2015)... Houston, TX (PRWEB) April 17, 2015 ... genomics and proteomics technologies, announced today that it ... sequencing system, an innovative multiplex PCR based targeted ... ultra-high resolution sequence analysis, that enables accurate detection ... pending Relay-PCR™ and Omega-Primer™ technologies. The company will ...
(Date:4/16/2015)... 16, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... quarter results on Thursday, April 30, 2015 at 4:00 ... will host a conference call at 4:30 PM Eastern ... company’s outlook for the future. , The conference call ... the homepage and in the Investor Relations section of ...
(Date:4/16/2015)... According to the 2014 Liberty ... source was ranked first among the leading causes ... lifting, pushing, pulling, holding, carrying, or throwing and ... David Round Company takes statistics like this very ... to develop and design equipment that prevents these ...
(Date:4/16/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... venture with G-treeBNT (ReGenTree LLC) has retained Ora, ... for the orphan disorder, neurotrophic keratopathy (NK), and ... syndrome (DES) in the U.S.  Both trials will ... year.  Each of these eye disorders was being ...
Breaking Biology Technology:LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: